All Articles

Decoy Therapeutics touts a revolutionary AI platform for multi-virus drugs, but faces financial hurdles. An upcoming investor event could define its future.

A major Canadian carrier is deploying Orange EV electric trucks, signaling a pivotal shift towards sustainable and cost-effective logistics, even in harsh climates.

A Charlotte dentist’s late-night parenting struggle sparks a patented invention, disrupting a beloved childhood tradition and making her a national innovator.

Enlyte's acquisition of PartsTrader signals a major shift in the auto claims industry, promising more efficiency but raising questions about competition.

The indoor air quality giant launches its roadshow, seeking to pay down debt and capitalize on soaring demand for healthier buildings and AI infrastructure.

Vyome is set to present promising Phase 2 data for VT-1953, a first-in-class treatment for a debilitating cancer complication with no approved drugs.

In a pivotal move from R&D to commercial scale, Zivo Bioscience partners with industry leader Cyanotech to meet global demand for its unique algal biomass.

The partnership grants 62,000+ financial advisors access to Harbor Group International's specialized, income-oriented multifamily private credit strategies.

CanTex Capital's landmark sale of a 1.3M sq ft portfolio to Partners Group highlights booming demand for DFW's strategic shallow bay industrial assets.

New data shows companies working with CEO Coaching International are seeing revenue and profit growth that nearly doubles and triples U.S. market averages.

Boston's Bio-IT World conference shifts from AI theory to execution, showcasing how the life sciences industry is now deploying AI to accelerate new therapies.

An expanded partnership aims to move businesses from AI experimentation to autonomous operations, tackling the critical 'last-mile problem' of value realization.

With a multi-billion dollar track record of IPOs and acquisitions, the veteran CEO's appointment signals Frazier's focus on navigating complex markets.

With new CEO Stan Lequin and private equity backing, Fidus Systems is pivoting to infuse AI into embedded design, signaling a new era of growth and M&A.

This April, families nationwide are walking to fund a new strategy for Lennox-Gastaut Syndrome, aiming to slash diagnosis times and find real cures.

Metazoa's new Intelligent Assistant for Salesforce goes beyond diagnostics, promising to actively help admins and developers remediate org complexity.

Energy Capital Partners is buying back nuclear services leader EnergySolutions, signaling Wall Street's growing confidence in nuclear's role in the energy future.

Hundreds of thousands of U.S.-born children live in exile after parental deportation. A new initiative aims to restore their rights and build a path home.

Amid financial headwinds, radiation therapy firm Accuray appoints a proven sales leader to spearhead a critical commercial transformation.

With its public debut on the horizon, S&P Global Mobility hires a seasoned expert in corporate separations to lead its financial structuring.